Compagnie Lombard Odier SCmA’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
– Sell
-20,000
Closed -$809K – 827
2016
Q4
$809K Hold
20,000
– – 0.02% 279
2016
Q3
$764K Hold
20,000
– – 0.02% 304
2016
Q2
$837K Hold
20,000
– – 0.02% 283
2016
Q1
$803K Buy
20,000
+19,785
+9,202% +$795K 0.02% 283
2015
Q4
$9K Hold
215
– – ﹤0.01% 867
2015
Q3
$11K Buy
215
+140
+187% +$7.13K ﹤0.01% 745
2015
Q2
$4K Sell
75
-1,385
-95% -$70.2K ﹤0.01% 795
2015
Q1
$72K Sell
1,460
-2,890
-66% -$138K ﹤0.01% 722
2014
Q4
$199K Buy
+4,350
New +$211K 0.01% 417
2014
Q2
– Sell
-150
Closed -$8K – 898
2014
Q1
$8K Hold
150
– – ﹤0.01% 831
2013
Q4
$8K Buy
+150
New +$7.74K ﹤0.01% 819

Other funds holding SNY

Compagnie Lombard Odier SCmA's SNY Position: Q1 2017 in Review

Compagnie Lombard Odier SCmA sold out of Sanofi (SNY) in Q1 2017, closing a stake of 20,000 shares — an estimated $809K sold.

Compagnie Lombard Odier SCmA first reported a position in SNY in Q4 2013 and held it in 11 quarters. The position peaked at $837K in Q2 2016. 455 funds tracked by Wall St. Rank hold SNY as of Q1 2017.

  • Compagnie Lombard Odier SCmA reported no remaining Sanofi position as of Q1 2017 after selling out during the quarter.
  • Compagnie Lombard Odier SCmA sold 20,000 Sanofi shares in Q1 2017, an estimated $809K.
  • Compagnie Lombard Odier SCmA first reported a position in Sanofi in Q4 2013 and held it in 11 quarters.
  • Compagnie Lombard Odier SCmA's Sanofi position peaked at $837K in Q2 2016.
  • 455 funds tracked by Wall St. Rank held Sanofi as of Q1 2017.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q1 2017, filed 15 May 2017.